“The ‘evidence’ is extraordinarily weak, at least as far as this paper goes,” said Margaret Haney, a professor of neurobiology at Columbia University, where she is directs cannabis research.
A new brain cancer study is testing an ultrasound technology developed at Columbia to determine if the technology can open the blood-brain barrier and improve delivery of chemotherapy.
Columbia researchers have developed a way to gently collect stem cells from the airways of infants in the hope of finding new ways to prevent respiratory diseases common in premature babies.
Twelve Columbia research teams have been awarded Columbia Life Science Accelerator pilot grants to develop technologies that aim to change the way patients are treated or diagnosed.
“The fear is that with the attention to vaccination, which is our major line of defense, this will result in a de-emphasis on the other tools in the toolbox,” Dr. Wafaa El-Sadr said last week.
A new initiative on human tissue immunity and disease, led by Donna Farber, PhD, will be launched this July in the VP&S Department of Microbiology and Immunology.
Nour Makarem, an assistant professor of epidemiology at Columbia, said, “This is robust evidence, novel evidence that higher intakes of soda are involved in a higher risk for colorectal cancer."
